King Edward Medical University

kemu.edu.pk

Live pipeline data from ClinicalTrials.gov, refreshed daily.

Total trials

73

Active

21

Phase 3

9

Total enrollment

7,549

Pipeline matrix

Showing 14 of 14 active programs · click any cell for trials

InterventionEarly Phase 1Phase 1Phase 2Phase 3Phase 4N/ATotal
G-CSF1
Antibiotics only1
Rosuvastatin 20 mg/day1
Atorvastatin 40 mg1
Buffered Local Anesthesia1
Vonoprazan 20 mg1
Tranexamic Acid1
Lactated Ringer 500ml1
Lactated Ringer 1000ml1
Lignocaine Ointment1
Glyceryl Trinitrate Ointment 0.2%1
Calcium carbonate plus vitamin D31
intralesional bleomycin1
5-flourouracil and triamcinolone acetonide1

Next readouts

  • 2025-12
  • 2025-12-26
  • 2026-01-01
  • 2026-01-30
  • 2026-02-20
  • 2026-05-31
  • 2026-06-30
  • 2026-07-28
  • 2026-12-31

Top conditions

  • COVID-193
  • Inguinal Hernia3
  • Postoperative Pain2
  • Burns2
  • Hernia, Inguinal1
  • Shoulder Pain1
  • Abdominal Pain (AP)1
  • Diarrhoea;Acute1

Frequently asked questions about King Edward Medical University

How many clinical trials does King Edward Medical University have on ClinicalTrials.gov?
King Edward Medical University is listed as the lead sponsor on 73 clinical trials in ClinicalTrials.gov, 21 of which are currently active (recruiting, enrolling, or ongoing).
How many of King Edward Medical University's trials are in Phase 3?
9 of King Edward Medical University's trials are in Phase 3, spread across 14 active drug programs.
What therapeutic areas does King Edward Medical University focus on?
King Edward Medical University's most-studied conditions on ClinicalTrials.gov are COVID-19, Inguinal Hernia, Postoperative Pain, Burns, Hernia, Inguinal.
When are King Edward Medical University's next clinical trial readouts?
King Edward Medical University has 9 upcoming primary-completion readouts tracked here; the soonest is “"Lignocaine vs GTN Ointment for Postoperative Pain After Hemorrhoidectomy")”, expected around 2025-12.